Maryland HB 1397: Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)

Status: Approved by the Governor - Chapter 405 (as of 2022-05-16)

State: Maryland · Session: 2022 · Bill: HB 1397

Sponsors: B. Barnes, Bagnall, Bhandari, Carey, Carr, Charles, Chisholm, Cullison, Henson, Hill, Howell, Johnson, K. Young, Kaiser, Kelly, Kerr, Kipke, Landis, Lehman, Morgan, Pena-Melnyk, Pendergrass, R. Lewis, Reilly, Reznik

View Maryland HB 1397 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.